Crossmark

Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort

Crossref DOI link: https://doi.org/10.1186/s13075-024-03392-9

Published Online: 2024-09-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ruscitti, Piero

Currado, Damiano

Rivellese, Felice

Vomero, Marta

Navarini, Luca

Cipriani, Paola

Pitzalis, Costantino

Giacomelli, Roberto
Funding

Funding for this research was provided by:

PRIN 2022 (2022AT8STS, C53D23000580008, 2022AT8STS, C53D23000580008)

National Institute for Health Research Barts Biomedical Research Centre (NIHR203330)
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Received: 6 January 2024

Accepted: 3 September 2024

First Online: 28 September 2024

Declarations

:

: All patients provided written informed consent, and the study received local ethics approval (PEAC LREC: 05/Q0703/198).

: Not applicable, all the patients’ data are de-identified.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below